arginyl-glycyl-aspartic acid has been researched along with fluorides in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avila, G; Galindo-Moreno, P; Misch, K; Wang, HL | 1 |
| Hong, S; Im, K; Kang, JH; Kang, M; Lee, J; Lee, TS; Lim, SM; Park, S; Ryu, J; Song, R | 1 |
| Chen, X; Guo, J; Guo, N; Hu, S; Kiesewetter, DO; Lang, L; Ma, Y; Niu, G; Sun, Z; Xie, Q; Zhu, L | 1 |
1 review(s) available for arginyl-glycyl-aspartic acid and fluorides
| Article | Year |
|---|---|
Implant surface treatment using biomimetic agents.
Topics: Biomimetic Materials; Bone Morphogenetic Proteins; Ceramics; Chitosan; Coated Materials, Biocompatible; Collagen Type I; Dental Implants; Dental Materials; Fluorides; Humans; Intercellular Signaling Peptides and Proteins; Oligopeptides; Osseointegration; Surface Properties | 2009 |
2 other study(ies) available for arginyl-glycyl-aspartic acid and fluorides
| Article | Year |
|---|---|
RGD peptide-conjugated multimodal NaGdF4:Yb3+/Er3+ nanophosphors for upconversion luminescence, MR, and PET imaging of tumor angiogenesis.
Topics: Animals; Cell Line, Tumor; Dimerization; Erbium; Feasibility Studies; Fluorides; Gadolinium; Glioblastoma; Humans; Integrin alphaVbeta3; Iodine Radioisotopes; Luminescent Agents; Luminescent Measurements; Magnetic Resonance Imaging; Mice; Molecular Imaging; Nanostructures; Neovascularization, Pathologic; Oligopeptides; Polyethylene Glycols; Positron-Emission Tomography; Ytterbium | 2013 |
Comparison of three dimeric 18F-AlF-NOTA-RGD tracers.
Topics: Aluminum Compounds; Animals; Cell Line, Tumor; Dimerization; Fluorides; Fluorine Radioisotopes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Mice; Oligopeptides; Organ Specificity; Radioactive Tracers; Tissue Distribution; Xenograft Model Antitumor Assays | 2014 |